These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures. Chronopoulou L, Massimi M, Giardi MF, Cametti C, Devirgiliis LC, Dentini M, Palocci C. Colloids Surf B Biointerfaces; 2013 Mar 01; 103():310-7. PubMed ID: 23261553 [Abstract] [Full Text] [Related]
3. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound. Li Z, Huang H, Huang L, Du L, Sun Y, Duan Y. Int J Mol Sci; 2017 Apr 13; 18(4):. PubMed ID: 28406431 [Abstract] [Full Text] [Related]
4. Polyelectrolyte coated polymeric nanoparticles for controlled release of docetaxel. Agrawal R, Shanavas A, Yadav S, Aslam M, Bahadur D, Srivastava R. J Biomed Nanotechnol; 2012 Feb 13; 8(1):19-28. PubMed ID: 22515091 [Abstract] [Full Text] [Related]
5. Design and in vitro evaluation of biocompatible dexamethasone-loaded nanoparticle dispersions, obtained from nano-emulsions, for inhalatory therapy. Fornaguera C, Llinàs M, Solans C, Calderó G. Colloids Surf B Biointerfaces; 2015 Jan 01; 125():58-64. PubMed ID: 25437064 [Abstract] [Full Text] [Related]
6. Dexamethasone dipropionate loaded nanoparticles of α-elastin-g-PLGA for potential treatment of restenosis. Palumbo FS, Rigogliuso S, Ghersi G, Pitarresi G, Fiorica C, Di Stefano M, Giammona G. Mol Pharm; 2013 Dec 02; 10(12):4603-10. PubMed ID: 24206105 [Abstract] [Full Text] [Related]
7. Intra-Articular Formulation of GE11-PLGA Conjugate-Based NPs for Dexamethasone Selective Targeting-In Vitro Evaluation. Chiesa E, Pisani S, Colzani B, Dorati R, Conti B, Modena T, Braekmans K, Genta I. Int J Mol Sci; 2018 Aug 06; 19(8):. PubMed ID: 30082640 [Abstract] [Full Text] [Related]
8. Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide. O'Donnell A, Moollan A, Baneham S, Ozgul M, Pabari RM, Cox D, Kirby BP, Ramtoola Z. J Pharm Pharmacol; 2015 Apr 06; 67(4):525-36. PubMed ID: 25515568 [Abstract] [Full Text] [Related]
9. Effects of surfactants on the properties of PLGA nanoparticles. Menon JU, Kona S, Wadajkar AS, Desai F, Vadla A, Nguyen KT. J Biomed Mater Res A; 2012 Aug 06; 100(8):1998-2005. PubMed ID: 22566409 [Abstract] [Full Text] [Related]
10. Effects of dexamethasone-loaded PLGA microspheres on human fetal osteoblasts. Dawes GJ, Fratila-Apachitei LE, Necula BS, Apachitei I, van Leeuwen JP, Duszczyk J, Eijken M. J Biomater Appl; 2012 Nov 06; 27(4):477-83. PubMed ID: 21862514 [Abstract] [Full Text] [Related]
11. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Kim DH, Martin DC. Biomaterials; 2006 May 06; 27(15):3031-7. PubMed ID: 16443270 [Abstract] [Full Text] [Related]
12. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Chen H, Xie LQ, Qin J, Jia Y, Cai X, Nan W, Yang W, Lv F, Zhang QQ. Colloids Surf B Biointerfaces; 2016 Feb 01; 138():1-9. PubMed ID: 26638176 [Abstract] [Full Text] [Related]
13. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Laquintana V, Denora N, Lopalco A, Lopedota A, Cutrignelli A, Lasorsa FM, Agostino G, Franco M. Mol Pharm; 2014 Mar 03; 11(3):859-71. PubMed ID: 24410438 [Abstract] [Full Text] [Related]
14. Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. Zeisser-Labouèbe M, Lange N, Gurny R, Delie F. Int J Pharm; 2006 Dec 01; 326(1-2):174-81. PubMed ID: 16930882 [Abstract] [Full Text] [Related]
15. Functional polymeric nanoparticles for dexamethasone loading and release. Fratoddi I, Venditti I, Cametti C, Palocci C, Chronopoulou L, Marino M, Acconcia F, Russo MV. Colloids Surf B Biointerfaces; 2012 May 01; 93():59-66. PubMed ID: 22227016 [Abstract] [Full Text] [Related]
16. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem. Nandakumar V, Geetha V, Chittaranjan S, Doble M. Biomed Pharmacother; 2013 Jun 01; 67(5):431-6. PubMed ID: 23583192 [Abstract] [Full Text] [Related]
17. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles. Han S, Liu Y, Nie X, Xu Q, Jiao F, Li W, Zhao Y, Wu Y, Chen C. Small; 2012 May 21; 8(10):1596-606. PubMed ID: 22411637 [Abstract] [Full Text] [Related]
18. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy. Tao W, Zeng X, Liu T, Wang Z, Xiong Q, Ouyang C, Huang L, Mei L. Acta Biomater; 2013 Nov 21; 9(11):8910-20. PubMed ID: 23816645 [Abstract] [Full Text] [Related]
19. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide. Kirby BP, Pabari R, Chen CN, Al Baharna M, Walsh J, Ramtoola Z. J Pharm Pharmacol; 2013 Oct 21; 65(10):1473-81. PubMed ID: 24028614 [Abstract] [Full Text] [Related]
20. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells. Şengel-Türk CT, Hasçiçek C, Dogan AL, Esendagli G, Guc D, Gönül N. Drug Dev Ind Pharm; 2012 Sep 21; 38(9):1107-16. PubMed ID: 22348284 [Abstract] [Full Text] [Related] Page: [Next] [New Search]